WGRX

+ Watchlist + Portfolio

Wellgistics Health, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.00
52-Week Range: $2.48 – $97.50
Market Cap: $182.88M
P/E (TTM): —
EPS (TTM): -43.87
Dividend Yield: —

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -79.18%
Gross Margin: -49.51%
Operating Margin: -385.72%
Profit Margin: 0.00%
Current Ratio: 0.09
Debt/Equity: —
Total Debt: $28.73M
Free Cash Flow: $-6.76M
Revenue Growth: -85.60%
Earnings Growth: —
Enterprise Value: $37.66M

WGRX Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$32.78M	$0.00	$18.13M	$23.34M
Cost of Revenue	$27.03M	$0.00	$16.36M	$29.76M
Gross Profit	$5.75M	$0.00	$1.77M	-$6.43M
Research & Development	$1.40K	$375.00	—	—
Selling, General & Admin	$7.08M	$2.88M	$6.80M	$71.56M
Operating Expenses	$9.17M	$2.88M	$7.91M	$74.77M
Operating Income	-$3.42M	-$2.88M	-$6.15M	-$81.19M
EBITDA	-$369.03K	-$2.88M	-$4.91M	-$93.48M
Pretax Income	-$2.74M	-$2.90M	-$6.86M	-$101.27M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$2.74M	-$2.90M	-$6.86M	-$101.27M
Diluted EPS	-2.90	-3.00	-7.50	-71.50
Diluted Shares	945041	894400	945041	1.42M

WGRX Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$0.00	$1.36K	$1.03M	$42.57K
Receivables	$0.00	$337.00K	$3.75M	$1.14M
Inventory	—	$0.00	$9.52M	$1.64M
Current Assets	$0.00	$338.36K	$15.17M	$2.82M
Total Assets	$0.00	$338.36K	$57.33M	$30.46M
Current Liabilities	$5.25K	$2.89M	$38.05M	$29.78M
Long-Term Debt	—	$350.00K	$11.46M	$12.60M
Total Debt	—	$350.00K	$25.11M	$24.77M
Total Liabilities	$5.25K	$3.24M	$50.60M	$42.91M
Retained Earnings	-$5.25K	-$2.90M	-$9.76M	-$111.03M
Shareholders' Equity	-$5.25K	-$2.90M	$6.73M	-$12.45M
Working Capital	-$5.25K	-$2.55M	-$22.88M	-$26.96M
Net Debt	—	$348.64K	$22.46M	$23.63M

WGRX Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$0.00	-$349.14K	-$1.22M	-$10.86M
Capital Expenditure	—	—	-$377.29K	-$881.53K
Free Cash Flow	$0.00	-$349.14K	-$1.60M	-$11.74M
Depreciation & Amortisation	—	$0.00	$1.11M	$3.21M
Stock-Based Compensation	—	$0.00	$1.08M	$54.79M
Investing Cash Flow	—	$0.00	$469.07K	-$881.53K
Financing Cash Flow	$0.00	$350.50K	$1.78M	$10.75M
Net Change in Cash	—	$1.36K	$1.03M	-$985.76K

WGRX Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$10.86M	$7.79M	$3.01M	$1.67M	$1.56M
Cost of Revenue	$10.17M	$7.29M	$2.78M	$9.53M	$1.39M
Gross Profit	$692.64K	$505.75K	$231.01K	-$7.86M	$170.22K
Selling, General & Admin	$31.24M	$5.20M	$30.98M	$4.14M	$5.83M
Operating Expenses	$32.04M	$6.01M	$31.78M	$4.94M	$6.19M
Operating Income	-$31.35M	-$5.50M	-$31.55M	-$12.80M	-$6.02M
EBITDA	-$30.53M	-$4.69M	-$32.09M	-$26.17M	-$5.31M
Pretax Income	-$32.43M	-$6.67M	-$34.32M	-$27.85M	-$7.74M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	-$32.43M	-$6.67M	-$34.32M	-$27.85M	-$7.74M
Diluted EPS	-31.00	-5.50	-23.00	—	-3.50
Diluted Shares	1.04M	1.24M	1.49M	—	2.09M

WGRX Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$2.52M	$419.94K	$4.23M	$42.57K	$51.73K
Receivables	$3.97M	$3.99M	$1.10M	$1.14M	$996.35K
Inventory	$9.73M	$9.03M	$7.49M	$1.64M	$1.71M
Current Assets	$16.55M	$13.51M	$12.82M	$2.82M	$2.76M
Total Assets	$58.06M	$54.23M	$52.78M	$30.46M	$30.13M
Current Liabilities	$46.23M	$42.40M	$32.74M	$29.78M	$32.20M
Long-Term Debt	$6.40M	$10.10M	$12.60M	$12.60M	$12.60M
Total Debt	$25.74M	$24.87M	$26.20M	$24.77M	$28.91M
Total Liabilities	$53.58M	$53.32M	$46.00M	$42.91M	$45.19M
Retained Earnings	-$42.19M	-$48.86M	-$83.18M	-$111.03M	-$118.77M
Shareholders' Equity	$4.48M	$905.25K	$6.78M	-$12.45M	-$15.06M
Working Capital	-$29.67M	-$28.89M	-$19.92M	-$26.96M	-$29.44M
Net Debt	$21.73M	$23.08M	$20.81M	$23.63M	$27.90M

WGRX Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.35M	-$2.08M	-$1.14M	-$6.29M	-$3.41M
Capital Expenditure	-$273.13K	-$131.93K	-$221.09K	-$255.38K	-$205.10K
Free Cash Flow	-$1.62M	-$2.21M	-$1.36M	-$6.55M	-$3.62M
Depreciation & Amortisation	$802.87K	$802.80K	$802.80K	$802.60K	$356.82K
Stock-Based Compensation	$27.77M	$935.22K	$25.73M	$355.70K	$1.36M
Investing Cash Flow	-$273.13K	-$131.93K	-$221.09K	-$255.38K	-$205.10K
Financing Cash Flow	$3.11M	$114.28K	$5.17M	$2.36M	$3.63M
Net Change in Cash	$1.49M	-$2.10M	$3.81M	-$4.19M	$9.16K

Market Snapshot

About

Wellgistics Health, Inc. is a healthcare technology company that provides integrated solutions for health and wellness management. The company focuses on delivering innovative platforms and services that connect patients, providers, and payers to improve healthcare outcomes and reduce costs.